Affinity of ceftaroline and other β-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 1670-1677

  Kosowska Shick, K ^a   McGhee, P L ^a   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAROLINE; CEFTRIAXONE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1; PENICILLIN BINDING PROTEIN 1B; PENICILLIN BINDING PROTEIN 2; PENICILLIN BINDING PROTEIN 2A; PENICILLIN BINDING PROTEIN 2B; PENICILLIN BINDING PROTEIN 2X; PENICILLIN BINDING PROTEIN 3; PENICILLIN BINDING PROTEIN 4; PENICILLIN G; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG TARGETING; IC 50; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BINDING, COMPETITIVE; CEFOTAXIME; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; STREPTOCOCCUS PNEUMONIAE;

EID: 77951249813     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00019-10     Document Type: Article

References (65)

1. Appelbaum, P. C. 2006. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12(Suppl. 1): 16-23.
2. Asahi, Y., Y. Takeuchi, and K. Ubukata. 1999. Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother. 43:1252-1255.
3. Asahi, Y., and K. Ubukata. 1998. Association of a Thr-371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2267-2273.
4. Bozdogan, B., D. Esel, C. Whitener, F. A. Browne, and P. C. Appelbaum. 2003. Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J. Antimicrob. Chemother. 52:864-868.
5. Centers for Disease Control and Prevention. 2002. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR Morb. Mortal. Wkly. Rep. 51:902. http://www.cdc.gov/mmwr//preview/mmwrhtml/mm5126a1.htm.
6. Chambers, H. F. 1999. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J. Infect. Dis. 179(Suppl. 2):S353-S359.
7. Chambers, H. F., and M. Sachdeva. 1990. Binding of β-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 161:1170-1176.
8. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M07-A8. Eighth edition. Clinical Laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S17. Seventeenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S19. Nineteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Davies, T. A., M. G. Page, W. Shang, T. Andrew, M. Kania, and K. Bush. 2007. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51:2621-2624.
12. de Jonge, B. L., Y. S. Chang, D. Gage, and A. Tomasz. 1992. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. J. Biol. Chem. 267: 11248-11254.
13. de Jonge, B. L., T. Sidow, Y. S. Chang, H. Labischinski, B. Berger-Bachi, D. A. Gage, and A. Tomasz. 1993. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J. Bacteriol. 175:2779-2782.
14. del Campo, R., F. Cafini, M. I. Morosini, A. Fenoll, J. Linares, L. Alou, D. Sevillano, R. Canton, J. Prieto, and F. Baquero. 2006. Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillinresistant Streptococcus pneumoniae isolates in Spain. J. Antimicrob. Chemother. 57:983-986.
15. Fenoll, A., L. Aguilar, O. Robledo, M. J. Gimenez, J. J. Granizo, D. Biek, and D. Tarrago. 2008. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime. Antimicrob. Agents Chemother. 52:4209-4210.
16. Ge, Y., D. Biek, G. H. Talbot, and D. F. Sahm. 2008. In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States. Antimicrob. Agents Chemother. 52:3398-3407.
17. Georgopapadakou, N. H., B. A. Dix, and Y. R. Mauriz. 1986. Possible physiological functions of penicillin-binding proteins in Staphylococcus aureus. Antimicrob. Agents Chemother. 29:333-336.
18. Grebe, T., and R. Hakenbeck. 1996. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactam antibiotics. Antimicrob. Agents Chemother. 40:829-834.
19. Guignard, B., J. M. Entenza, and P. Moreillon. 2005. Beta-lactams against methicillin-resistant Staphylococcus aureus. Curr. Opin. Pharmacol. 5:479-489.
20. Hackbarth, C. J., T. Kocagoz, S. Kocagoz, and H. F. Chambers. 1995. Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance. Antimicrob. Agents Chemother. 39:103-106.
21. Hakenbeck, R. 1999. Beta-lactam-resistant Streptococcus pneumoniae: epidemiology and evolutionary mechanism. Chemotherapy 45:83-94.
22. Hakenbeck, R. 1998. Mosaic genes and their role in penicillin-resistant Streptococcus pneumoniae. Electrophoresis 19:597-601.
23. Hakenbeck, R., A. Konig, I. Kern, M. van der Linden, W. Keck, D. Billot- Klein, R. Legrand, B. Schoot, and L. Gutmann. 1998. Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level beta-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J. Bacteriol. 180:1831-1840.
24. Hakenbeck, R., S. Tornette, and N. F. Adkinson. 1987. Interaction of nonlytic β-lactams with penicillin-binding proteins in Streptococcus pneumoniae. J. Gen. Microbiol. 133:755-760.
25. Hebeisen, P., I. Heinze-Krauss, P. Angehrn, P. Hohl, M. G. Page, and R. L. Then. 2001. In vitro and in vivo properties of Ro 63-9141, a novel broadspectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 45:825-836.
26. Higashi, Y., A. Wakabayashi, Y. Matsumoto, Y. Watanabe, and A. Ohno. 1999. Role of inhibition of penicillin binding proteins and cell wall crosslinking by β-lactam antibiotics in low- and high-level methicillin resistance of Staphylococcus aureus. Chemotherapy 45:37-47.
27. Ishikawa, T., N. Matsunaga, H. Tawada, N. Kuroda, Y. Nakayama, Y. Ishibashi, M. Tomimoto, Y. Ikeda, Y. Tagawa, Y. Iizawa, K. Okonogi, S. Hashiguchi, and A. Miyake. 2003. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties. Bioorg. Med. Chem. 11:2427-2437.
28. Jones, R. N., T. R. Fritsche, H. S. Sader, and J. E. Ross. 2007. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn. Microbiol. Infect. Dis. 59:309-317.
29. Julian, K., K. Kosowska-Shick, C. Whitener, M. Roos, H. Labischinski, A. Rubio, L. Parent, L. Ednie, L. Koeth, T. Bogdanovich, and P. C. Appelbaum. 2007. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis. Antimicrob. Agents Chemother. 51:3445-3448.
30. Katayama, Y., H. Z. Zhang, and H. F. Chambers. 2004. PBP 2a mutations producing very-high-level resistance to β-lactams. Antimicrob. Agents Chemother. 48:453-459.
31. Kosowska, K., M. R. Jacobs, S. Bajaksouzian, L. Koeth, and P. C. Appelbaum. 2004. Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs. Antimicrob. Agents Chemother. 48:4020-4022.
32. Kosowska-Shick, K., L. M. Ednie, P. McGhee, and P. C. Appelbaum. 2009. Comparative antipneumococcal activities of sulopenem and other drugs. Antimicrob. Agents Chemother. 53:2239-2247.
33. Kosowska-Shick, K., L. M. Ednie, P. McGhee, K. Smith, C. D. Todd, A. Wehler, and P. C. Appelbaum. 2008. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. Antimicrob. Agents Chemother. 52: 4510-4513.
34. Kosowska-Shick, K., P. McGhee, and P. C. Appelbaum. 2009. Binding of faropenem and other β-lactam agents to penicillin-binding proteins of pneumococci with various β-lactam susceptibilities. Antimicrob. Agents Chemother. 53:2176-2180.
35. Laible, G., B. G. Spratt, and R. Hakenbeck. 1991. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillinresistant clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 5:1993-2002.
36. Leski, T. A., and A. Tomasz. 2005. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J. Bacteriol. 187:1815-1824.
37. Lim, D., and N. C. Strynadka. 2002. Structural basis for the β-lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat. Struct. Biol. 9:870-876.
38. Mainardi, J. L., D. M. Shlaes, R. V. Goering, J. H. Shlaes, J. F. Acar, and F. W. Goldstein. 1995. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J. Infect. Dis. 171:1646-1650.
39. Malouin, F., J. Blais, S. Chamberland, M. Hoang, C. Park, C. Chan, K. Mathias, S. Hakem, K. Dupree, E. Liu, T. Nguyen, and M. N. Dudley. 2003. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal β-lactamases. Antimicrob. Agents Chemother. 47:658-664.
40. McGee, L., D. Biek, Y. Ge, M. Klugman, M. du Plessis, A. M. Smith, B. Beall, C. G. Whitney, and K. P. Klugman. 2009. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 53:552-556.
41. Memmi, G., S. R. Filipe, M. G. Pinho, Z. Fu, and A. Cheung. 2008. Staphylococcus aureus PBP4 is essential for β-lactam resistance in community-acquired methicillin-resistant strains. Antimicrob. Agents Chemother. 52: 3955-3966.
42. Moisan, H., M. Pruneau, and F. Malouin. 22 January 2010, posting date. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae. J. Antimicrob. Chemother. [Epub ahead of print.] doi:10.1093/jac/dkp503.
43. Morrissey, I., Y. Ge, and R. Janes. 2009. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia. Int. J. Antimicrob. Agents 33:515-519.
44. Munoz, R., C. G. Dowson, M. Daniels, T. J. Coffey, C. Martin, R. Hakenbeck, and B. G. Spratt. 1992. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 6:2461-2465.
45. Mushtaq, S., M. Warner, Y. Ge, K. Kaniga, and D. M. Livermore. 2007. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. J. Antimicrob. Chemother. 60:300-311.
46. Nagai, K., T. A. Davies, M. R. Jacobs, and P. C. Appelbaum. 2002. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob. Agents Chemother. 46: 1273-1280.
47. Okonogi, K., Y. Noji, M. Nakao, and A. Imada. 1995. The possible physiological roles of penicillin-binding proteins of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. J. Infect. Chemother. 1:50-58.
48. Okonogi, K., Y. Noji, M. Kondo, A. Imada, and T. Yokota. 1989. Emergence of methicillin-resistant clones from cephamycin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 24:637-645.
49. Parvez, M. A., H. Shibata, T. Nakano, S. Niimi, N. Fujii, N. Arakaki, and T. Higuti. 2008. No relationship exists between PBP 2a amounts expressed in different MRSA strains obtained clinically and their β-lactam MIC values. J. Med. Invest. 55:246-253.
50. Pereira, S. F. F., A. O. Henriques, M. G. Pinho, H. de Lencastre, and A. Tomasz. 2007. Role of PBP1 in cell division of Staphylococcus aureus. J. Bacteriol. 189:3525-3531.
51. Pinho, M. G., H. de Lencastre, and A. Tomasz. 2001. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drugresistant staphylococci. Proc. Natl. Acad. Sci. U. S. A. 98:10886-10891.
52. Pucci, M. J., and T. J. Dougherty. 2008. A method to assay penicillin-binding proteins. Methods Mol. Med. 142:131-141.
53. Regev-Yochay, G., K. Trzcinski, C. M. Thompson, M. Lipsitch, and R. Malley. 2007. SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J. Bacteriol. 189:6532-6539.
54. Sanbongi, Y., T. Ida, M. Ishikawa, Y. Osaki, H. Kataoka, T. Suzuki, K. Kondo, F. Ohsawa, and M. Yonezawa. 2004. Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan. Antimicrob. Agents Chemother. 48:2244-2250.
55. Sieradzki, K., M. G. Pinho, and A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:18942-18946.
56. Sifaoui, F., M. D. Kitzis, and L. Gutmann. 1996. In vitro selection of onestep mutants of Streptococcus pneumoniae resistant to different oral β-lactam antibiotics is associated with alterations of PBP2x. Antimicrob. Agents Chemother. 40:152-156.
57. Smith, A. M., and K. P. Klugman. 1995. Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:859-867.
58. Song, M. D., M. Wachi, M. Doi, F. Ishino, and M. Matsuhashi. 1987. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett. 221:167-171.
59. Spratt, B. G. 1994. Resistance to antibiotics mediated by target alterations. Science 264:388-393.
60. Utsui, Y., and T. Yokota. 1985. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 28:397-403.
61. Villegas-Estrada, A., M. Lee, D. Hesek, S. B. Vakulenko, and S. Mobashery. 2008. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA β-lactam antibiotics. J. Am. Chem. Soc. 130:9212-9213.
62. Williamson, R., R. Hakenbeck, and A. Tomasz. 1980. In vivo interaction of β-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 18:629-637.
63. Zerfass, I., R. Hakenbeck, and D. Denapaite. 2009. An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338. Antimicrob. Agents Chemother. 53:1107-1115.
64. Zhanel, G. G., G. Sniezek, F. Schweizer, S. Zelenitsky, P. R. Lagace-Wiens, E. Rubinstein, A. S. Gin, D. J. Hoban, and J. A. Karlowsky. 2009. Ceftaroline: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Drugs 69:809-831.
65. Zhao, G., T. I. Meier, S. D. Kahl, K. R. Gee, and L. C. Blaszczak. 1999. BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob. Agents Chemother. 43: 1124-1128.